How T-cells are activated and become activators by cell-cell activation

J. Dayer (Geneva, Switzerland)

Source: Lung Science Conference 2003 - Inflammation and Respiratory Disease
Number: 3
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Dayer (Geneva, Switzerland). How T-cells are activated and become activators by cell-cell activation. Lung Science Conference 2003 - Inflammation and Respiratory Disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How T-lymphocytes are activated and become activators by cell-cell interaction
Source: Eur Respir J 2003; 22: 10S-15S
Year: 2003


Mast cell activation leads to migration of T-cells in vitro
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007


A differential role for ceramide kinase in antigen/FcεRI mediated mast cell activation and function
Source: Eur Respir J 2006; 28: Suppl. 50, 231s
Year: 2006

Effect of activated protein C on the thrombin signalling pathway in alveolar epithelial cells
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009

Anti–fibrotic efficacy of Lck inhibitor via the suppression of TGF–ß production in regulatory T cells
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


Stimulation of NOD1 induces RIP2, TAK1 and p38 MAPK dependent pro-inflammatory signalling in human lung microvascular endothelial cells
Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment
Year: 2011


Involvement of NFkB activation and c-JUN phosphorylation in bronchial epithelial cells by CD-40-CD40L pathway
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002

PI3K and notch signal pathways coordinately regulate the activation and proliferation of T lymphocytes in asthma
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

AMP affects intracellular Ca2+ signalling, migration, cytokine secretion and T-cell priming capacity of human dendritic cells
Source: Annual Congress 2009 - Airway cell biology
Year: 2009


Eosinophil adhesion to cholinergic nerve cells induces NFκB activation via the interleukin-1 receptor associated kinase (IRAK) pathway and upregulates ICAM-1 expression
Source: Eur Respir J 2003; 22: Suppl. 45, 10s
Year: 2003

The effect of Immunotherapy on the expression of costimulatory pathway molecules on dendritic cells and T cells in asthmatic mice
Source: Eur Respir J 2003; 22: Suppl. 45, 483s
Year: 2003

Thrombin induces epithelial-mesenchymal transition via PAR1, PKC and ERK1/2 pathways in A549 cells
Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities
Year: 2012


NFAT subtypes in regulating Th2 lymphocytes
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Human rhinovirus induces the expression of the membrane bound form of its cellular receptor intercellular adhesion molecule 1via a tyrosine kinase dependent signal transduction pathway
Source: Eur Respir J 2001; 18: Suppl. 33, 160s
Year: 2001

TGFβ induced myofibroblast differentiation is independent of p38 activation, but requires TGFβR1 kinase activity and correlates with TGFβ-mediated SMAD signaling and TGFβ-responsive gene expression patterns in human lung fibroblasts
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004

A T cell-specific inhibitor of NF-kappaB and AP-1 suppresses lung fibrosis in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 101s
Year: 2004

The antimicrobial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands
Source: Eur Respir J 2006; 28: Suppl. 50, 582s
Year: 2006

Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007